Table 2.
Association between ER expression and clinicopathological parameters among the study participants (n = 114)
| Clinico-pathological parameters | ER Positive | ER Negative | Total | p-value |
|---|---|---|---|---|
| Median age at Diagnosis(min-max) | 42(22–75) | 41(27–65) | 0.284 | |
| Tumor Grade, n (%) | ||||
| I | 5(10) | 2(7) | 7(9) | |
| II | 18(36) | 14(50) | 32(41) | 0.480 |
| III | 27(54) | 12(43) | 39(50) | |
| Stage, n (%) | ||||
| I | 13(20) | 6(19) | 19(20) | |
| II | 27(42) | 10(31) | 37(39) | 0.639 |
| III | 22(34) | 14(44) | 36(37) | |
| IV | 2(3) | 2(6) | 4(4) | |
| Histological Type, n (%) | ||||
| Infiltrating ductal | 41(60) | 26(80) | 67(68) | 0.123 |
| Lobular | 6(10) | 0(0) | 6(6) | |
| Others/Not classified | 18(30) | 7(20) | 25(26) | |